Balarpan

Country of origin: Russia

Pharm-Group: Products that stimulate regeneration

Manufacturers: Eye Microsurgery (Russia)

International name: Balarpan

Dosage forms: eye drops 0.01%

Composition: 1 bottle contains 0.001 g of sulfated glycosaminoglycans in 10 ml of sodium chloride solution.

Indications for use:

1. Erosion and penetrating wounds of the cornea, conjunctiva and sclera.

2. Penetrating wounds of the cornea and sclera after surgical treatment.

3. Burns of the cornea, conjunctiva, sclera (chemical, thermal).

4. Damage to the cornea and sclera as a result of surgical interventions (keratomy, keratomileusis, keratoplasty, cataract extraction).

5. Keratitis.

6. Keratoconjunctivitis.

7. "Dry cornea"

8. Epithelial endothelial dystrophy of the cornea.

9. For vision correction, as a preventive and therapeutic agent.

10. As a prophylactic for involutional changes in the cornea.

Contraindications: None.

Side effect: No individual intolerance to the drug has been identified.

Interaction: No information.

Overdose: No information.

Special instructions: The drug "Balarpan" does not affect professional activities (driving vehicles, etc.).

Literature: Instructions for use of the drug "Balarpan", approved by the Pharmacological Committee of the Russian Ministry of Health on June 11, 1998.